Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrel

Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrel

Dual antithrombotic therapy (DAT) without aspirin reduces bleeding compared with triple antithrombotic therapy (TAT) in patients with atrial fibrillation who have undergone percutaneous coronary intervention, without apparently increasing ischemic events. A prospective pharmacodynamic study was perf...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark A. Sammut, Mohammed E. F. Rahman, Claire Bridge, Jessica Hanson, Heather Judge, Bethany Lynch, Emily Maz, Hannah McMellon, Janet Middle, Georgia Williamson, William A. E. Parker, Justin Lee, Robert F. Storey
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Platelets
Subjects:
Acute coronary syndrome
aspirin
atrial fibrillation
dual antithrombotic therapy
ticagrelor
triple antithrombotic therapy
Online Access:https://www.tandfonline.com/doi/10.1080/09537104.2025.2507037
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/09537104.2025.2507037

Similar Items